Atea Pharmaceuticals
AVIR
AVIR
126 hedge funds and large institutions have $396M invested in Atea Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 42 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
26% less call options, than puts
Call options by funds: $4.06M | Put options by funds: $5.47M
39% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 38
Holders
126
Holding in Top 10
–
Calls
$4.06M
Puts
$5.47M
Top Buyers
| 1 | +$14.8M | |
| 2 | +$6.96M | |
| 3 | +$6.84M | |
| 4 |
BlackRock
New York
|
+$6.09M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$4.19M |
Top Sellers
| 1 | -$10.2M | |
| 2 | -$5.33M | |
| 3 | -$3.27M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$2.52M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$2.17M |